The Trump administration is preparing to launch TrumpRx.com, an initiative aimed at lowering drug costs by aggregating direct-to-consumer access to branded prescription medications at discounted cash prices.
The promise is seductive: lower prices on brand-name medications, available to anyone willing to bypass their insurance and pay out of pocket.Read the rest…